Georgi H.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
- Phase 3 Study of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma
- Noninferiority of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide versus beclometasone dipropionate/formoterol fumarate in asthma
Data & Insights
Has run more than one trial at 140 of 437 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in treating complex respiratory conditions, with particular emphasis on non-cystic fibrosis bronchiectasis (NCFB) and its associated complications.
- Bronchiectasis Management
- Respiratory Infections
- Airway Disease Treatment
The investigator's work encompasses innovative therapeutic approaches for patients with chronic respiratory conditions.
Infectious Disease Management
Focuses on the treatment of respiratory tract infections, particularly those involving Pseudomonas aeruginosa and other potentially pathogenic microorganisms in bronchiectasis patients.
- Bacterial Infection Control
- Antimicrobial Therapy
- Pathogen Management
Their expertise extends to managing complex bacterial infections in compromised respiratory systems.
Therapeutic Innovation
Investigates novel treatment modalities including nebulized nitric oxide formulations for respiratory conditions, focusing on innovative delivery systems for respiratory medications.
- Inhaled Therapeutics
- Drug Delivery Systems
- Treatment Safety Assessment
The investigator evaluates advanced therapeutic options for patients with chronic respiratory infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.